During the past decade, Cullman Clinical Trials conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cullman Clinical Trials" #1 sponsor was "Exact Sciences Corporation" with 2 trials, followed by "Axcella Health, Inc" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Effector Therapeutics" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cullman Clinical Trials" #1 collaborator was "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cullman Clinical Trials" are "Colorectal Cancer" (2 trials), "COVID-19" (1 trials), "Corona Virus Infection" (1 trials), "Coronavirus Disease 2019" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Cullman Clinical Trials" in a lesser frequency.

Most popular intervention types in "Cullman Clinical Trials" are "Drug" (7 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AXA1125" (1 trials), "BFKB8488A" (1 trials), "BMS-963272" (1 trials) and "Blood Sample Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cullman Clinical Trials" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Cullman Clinical Trials". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Cullman Clinical Trials, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cullman Clinical Trials, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".